[Effect of DNA-tropic substances used jointly with tuberculostatic preparations on the development of drug resistance in Mycobacterium tuberculosis].
D000970:Antineoplastic Agents / Q000494:pharmacology*; D000995:Antitubercular Agents / Q000494:pharmacology*; D004269:DNA, Bacterial; D004305:Dose-Response Relationship, Drug; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D015643:Erythromycin Ethylsuccinate / Q000494:pharmacology; D007538:Isoniazid / Q000494:pharmacology; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D009581:Nitrofurans / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D013307:Streptomycin / Q000494:pharmacology
D000970:Antineoplastic Agents; D000995:Antitubercular Agents; D004269:DNA, Bacterial; D009581:Nitrofurans; D011804:Quinolines; D015643:Erythromycin Ethylsuccinate; D007538:Isoniazid; D013307:Streptomycin
Vliianie nekotorykh DNK-tropnykh veshchestv pri ikh sovmestnom ispol'zovanii s tuberkulostaticheskimi preparatami na razvitie lekarstvennoĭ ustoĭchivosti mikobakteriĭ tuberkuleza.